Ligand Pharmaceuticals
LGND
#3462
Rank
ยฃ2.93 B
Marketcap
ยฃ147.42
Share price
-4.03%
Change (1 day)
74.05%
Change (1 year)

Ligand Pharmaceuticals (LGND) - Total liabilities

Total liabilities on the balance sheet as of December 2025 : ยฃ0.40 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's total liabilities are ยฃ0.40 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Ligand Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-12-31ยฃ0.40 B354.82%
2024-12-31ยฃ88.71 M30.97%
2023-12-31ยฃ67.74 M-50.39%
2022-12-31ยฃ0.13 B-61.32%
2021-12-31ยฃ0.35 B-26.3%
2020-12-31ยฃ0.47 B-13.7%
2019-12-31ยฃ0.55 B0.65%
2018-12-31ยฃ0.55 B195.27%
2017-12-31ยฃ0.18 B-0.14%
2016-12-31ยฃ0.18 B22.53%
2015-12-31ยฃ0.15 B1.7%
2014-12-31ยฃ0.15 B349.21%
2013-12-31ยฃ33.4 M-30.58%
2012-12-31ยฃ48.11 M-33.46%
2011-12-31ยฃ72.31 M38.83%
2010-12-31ยฃ52.08 M-38.95%
2009-12-31ยฃ85.31 M-31.22%
2008-12-31ยฃ0.12 B70.95%
2007-12-31ยฃ72.56 M-52.41%
2006-12-31ยฃ0.15 B-38.13%
2005-12-31ยฃ0.24 B16.04%
2004-12-31ยฃ0.21 B8.07%
2003-12-31ยฃ0.19 B56.47%
2002-12-31ยฃ0.12 B3.87%
2001-12-31ยฃ0.12 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
ยฃ88.73 B 21,552.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ91.53 B 22,237.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ64.81 B 15,714.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ61.78 B 14,976.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
ยฃ10.52 B 2,467.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ63.50 B 15,395.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ53.94 B 13,063.18%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ45.86 B 11,092.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
ยฃ60.98 M-85.12%๐Ÿ‡บ๐Ÿ‡ธ USA